PMC:6019327 / 582415-583035 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6019327","sourcedb":"PMC","sourceid":"6019327","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6019327","text":"Currently, there is investigation into both simultaneous and staged hybrid procedures, with no clinical trials showing one strategy superior to the other. The Dual Epicardial Endocardial Persistent Atrial Fibrillation trial is a prospective randomized staged hybrid study using bipolar RF. The CONVERGE trial is a set of prospective randomized simultaneous hybrid trials using monopolar RF. These trials also use different operative approaches. There are a number of other ongoing multicenter trials that are likely to define the roles and lesion sets for treatment of patients with persistent AF using these strategies.","tracks":[]}